EUVIMEDEUVIMED entdecken
Multizentrische Studie

Transcatheter Mitral Valve Replacement With Atrial Fixation for Treatment of Atrial Functional Mitral Regurgitation

John T Saxon iD, Philippe Genereux iD, Vlasis Ninios iD, Thomas Waggoner, Naeem Tahirkheli, Marek Grygier iD, Krzysztof Wrobel iD, Matti Adam iD, Georg Nickenig, Tsuyoshi Kaneko iD, Paul Sorajja iD

Circulation: Cardiovascular Interventions · 2025-04 · 18 (4)

DOI: 10.1161/circinterventions.124.014985 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Circulation: Cardiovascular Interventions, 2025-04. Verfasst von John T Saxon und 10 weiteren Autor:innen. Beteiligte Einrichtung: University of Virginia Medical Center, Charlottesville (J.T.S.). Hauptthemen laut MEDLINE: Mitral Valve Insufficiency, Heart Valve Prosthesis Implantation, Mitral Valve, Cardiac Catheterization. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 16 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Many patients with atrial functional mitral regurgitation are not suitable candidates for surgery or transcatheter repair. For transcatheter mitral valve replacement, a common contraindication is the risk of left ventricular outflow tract obstruction, particularly in patients with atrial functional mitral regurgitation, who have characteristically small left ventricles. Herein, we examine the outcomes of transcatheter mitral valve replacement using the AltaValve system, which employs atrial fixation thus minimizing left ventricular outflow tract obstruction risk. METHODS: Patients with severe, symptomatic mitral regurgitation who were treated in the AltaValve early feasibility study or on the basis of a compassionate use exemption. The definition of atrial functional mitral regurgitation required the presence of: (1) severe mitral regurgitation; (2) atrial fibrillation; (3) normal left ventricular size; (4) left ventricular ejection fraction ≥50%; and (5) absence of organic mitral disease. Procedural outcomes, 30-day survival, and echo findings are reported. RESULTS: Fourteen patients (71% women, mean age 77.9 years, Society of Thoracic Surgeons Predicted Risk of Mortality score 5.4%) were treated, including 11 via transseptal delivery and 3 via a transapical approach. Technical success and mitral regurgitation reduction from severe to none/trace were achieved in all cases. There were no cases of left ventricular outflow tract obstruction. All-cause mortality at 30 days was 14% (2/14). Class III/IV New York Heart Association status was reduced from 79% at baseline to 0% at 30 days. At 30 days, 11 of 12 surviving patients had an available echocardiogram; mitral regurgitation severity was trace/none in 90.9% (10/11) and mild in 9.1% (1/11). CONCLUSIONS: The AltaValve system shows promising early procedural and clinical results for the unique anatomy of patients with atrial functional mitral regurgitation. Long-term clinical studies to demonstrate the benefit of this system are warranted.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mitral Valve InsufficiencyHeart Valve Prosthesis ImplantationMitral ValveCardiac CatheterizationHeart AtriaHumansFemaleAgedMaleTreatment OutcomeAged, 80 and overFeasibility StudiesSeverity of Illness IndexTime FactorsHeart Valve ProsthesisRisk FactorsRecovery of FunctionVentricular Function, LeftCompassionate Use TrialsProsthesis DesignVentricular Outflow ObstructionAtrial Function, Left

Stichwörter der Autor:innen

cardiac valvesheart valve prosthesis implantationmitral valvestroke volume

Autor:innen und Institutionen

  • University of Virginia Medical Center, Charlottesville (J.T.S.).
  • Gagnon Cardiovascular Institute, Morristown Medical Center, NJ (P.G.).
  • Interbalkan Medical Center, Thessaloniki, Greece (V.N.).
  • Tucson Medical Center, AZ (T.W.).
  • Oklahoma Heart Hospital, Oklahoma City (N.T.).
  • Poznan University of the Medical Sciences, Poland (M.G.).

ORCID-Profile: John T Saxon, Philippe Genereux, Vlasis Ninios, Marek Grygier, Krzysztof Wrobel, Matti Adam, Tsuyoshi Kaneko, Paul Sorajja

Zitieren

APA

Saxon, J. T., Genereux, P., Ninios, V., Waggoner, T., Tahirkheli, N., Grygier, M., Wrobel, K., Adam, M., Nickenig, G., Kaneko, T., & Sorajja, P. (2025). Transcatheter Mitral Valve Replacement With Atrial Fixation for Treatment of Atrial Functional Mitral Regurgitation. Circulation: Cardiovascular Interventions, 18(4). https://doi.org/10.1161/circinterventions.124.014985

Vancouver

Saxon JT, Genereux P, Ninios V, Waggoner T, Tahirkheli N, Grygier M, et al. Transcatheter Mitral Valve Replacement With Atrial Fixation for Treatment of Atrial Functional Mitral Regurgitation. Circulation: Cardiovascular Interventions. 2025;18(4). doi:10.1161/circinterventions.124.014985

BibTeX
@article{Saxon2025,
  author = {Saxon, John T and Genereux, Philippe and Ninios, Vlasis and Waggoner, Thomas and Tahirkheli, Naeem and Grygier, Marek and Wrobel, Krzysztof and Adam, Matti and Nickenig, Georg and Kaneko, Tsuyoshi and Sorajja, Paul},
  title = {Transcatheter Mitral Valve Replacement With Atrial Fixation for Treatment of Atrial Functional Mitral Regurgitation},
  journal = {Circulation: Cardiovascular Interventions},
  year = {2025},
  volume = {18},
  number = {4},
  doi = {10.1161/circinterventions.124.014985}
}
Kostenlos starten →